Journal ArticleOPEN ACCESS

Response to (K)RAS G12C and EGFR Inhibition in a Patient With NRAS G12C -Mutated Rectal Cancer

  • Möhrmann L
  • Cuberi A
  • Brückmann S
  • et al.
JCO Precision Oncology (2023) (7)
DOI: 10.1200/po.22.00666
6Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Möhrmann, L., Cuberi, A., Brückmann, S., Stasik, S., Heukamp, L. C., Bornhäuser, M., … Folprecht, G. (2023). Response to (K)RAS G12C and EGFR Inhibition in a Patient With NRAS G12C -Mutated Rectal Cancer. JCO Precision Oncology, (7). https://doi.org/10.1200/po.22.00666

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free